Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer

被引:0
作者
Ui-Soon Khoo
Hilmi Ozcelik
Annie NY Cheung
Louis WC Chow
Hextan YS Ngan
Susan J Done
A C T Liang
Vivian WY Chan
Gordon KH Au
Wing-Fung Ng
Cycles SP Poon
Yuet-Foon Leung
Florence Loong
Philip Ip
Gavin SW Chan
Irene L Andrulis
Jing Lu
Faith CS Ho
机构
[1] Queen Mary Hospital,Department of Pathology
[2] The University of Hong Kong,Department of Pathology and Laboratory Medicine and Samuel Lunenfeld Research Institute
[3] Mount Sinai Hospital,Department of Laboratory Medicine and Pathobiology
[4] University of Toronto,Department of Surgery
[5] Queen Mary Hospital,Department of Obstetrics and Gynecology
[6] The University of Hong Kong,Department of Radiation Therapy and Oncology
[7] Queen Mary Hospital,Department of Pathology
[8] The University of Hong Kong,Department of Pathology
[9] Queen Mary Hospital,Division of Preventive Oncology
[10] The University of Hong Kong,Department of Pathology and Immunology
[11] Ruttonjee Hospital,undefined
[12] Pamela Youde Nethersole Hospital,undefined
[13] Pathology Institute,undefined
[14] Jockey Club Polyclinic,undefined
[15] Sai Ying Pun,undefined
[16] CCO,undefined
[17] Monash University,undefined
来源
Oncogene | 1999年 / 18卷
关键词
somatic mutations; breast cancer; ovarian cancer; Chinese;
D O I
暂无
中图分类号
学科分类号
摘要
Inherited mutations in the BRCA1 gene confer increased susceptibility to breast and ovarian cancer. Its role in sporadic carcinogenesis is not well defined. Somatic mutations in breast cancers have not been reported and to date there are only three reports of somatic mutations in sporadic ovarian cancers. To investigate the contribution of BRCA1 mutations to sporadic breast and ovarian cancer in the Chinese population, we analysed 62 samples from Chinese women using the protein truncation test. There were 40 cases of breast cancer under age 50 and 22 cases of ovarian cancer, all unselected for family history. There was no age selection for the ovarian cancers. We found two somatic BRCA1 mutations in exon 11, one in a breast cancer and the other in an ovarian cancer, both of which result in truncated proteins. Our results indicate that somatic BRCA1 mutations, like somatic mutations in the BRCA2 gene, though very rare, can be found in both breast and ovarian cancers and support a tumor suppressor function for BRCA1 in sporadic tumors.
引用
收藏
页码:4643 / 4646
页数:3
相关论文
empty
未找到相关数据